메뉴 건너뛰기




Volumn 32, Issue 4, 2014, Pages 288-296

Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: A prospective matched pairs analysis

(22)  Stelljes, Matthias a   Krug, Utz a   Beelen, Dietrich W b   Braess, Jan c   Sauerland, Maria C a   Heinecke, Achim a   Ligges, Sandra a   Sauer, Tim a   Tschanter, Petra a   Thoennissen, Gabriela B a   Berning, Björna a   Kolb, Hans J e   Reichle, Albrecht d   Holler, Ernst d   Schwerdtfeger, Rainer f   Arnold, Renate g   Scheid, Christoph i   Mul̈ler Tidow, Carsten a   Woermann, Bernhard J h   Hiddemann, Wolfgang e   more..


Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

EID: 84897020217     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.50.5768     Document Type: Article
Times cited : (85)

References (29)
  • 1
    • 84879373604 scopus 로고    scopus 로고
    • Treatment of acute myeloid leukemia: Are we making progress?
    • Burnett AK: Treatment of acute myeloid leukemia: Are we making progress? Hematology Am Soc Hematol Educ Program 1-6, 2012
    • (2012) Hematology Am Soc Hematol Educ Program , pp. 1-6
    • Burnett, A.K.1
  • 2
    • 84867608512 scopus 로고    scopus 로고
    • Acute Myeloid Leukemia (AML): Different treatment strategies versus a common standard arm - Combined prospective analysis by the German AML intergroup
    • Büchner T, Schlenk RF, Schaich M, et al: Acute Myeloid Leukemia (AML): Different treatment strategies versus a common standard arm - Combined prospective analysis by the German AML intergroup. J Clin Oncol 30:3604-3610, 2012
    • (2012) J Clin Oncol , vol.30 , pp. 3604-3610
    • Büchner, T.1    Schlenk, R.F.2    Schaich, M.3
  • 3
    • 70349467775 scopus 로고    scopus 로고
    • Anthracycline dose intensification in acute myeloid leukemia
    • Fernandez HF, Sun Z, Yao X, et al: Anthracycline dose intensification in acute myeloid leukemia. N Engl J Med 361:1249-1259, 2009
    • (2009) N Engl J Med , vol.361 , pp. 1249-1259
    • Fernandez, H.F.1    Sun, Z.2    Yao, X.3
  • 4
    • 77955914238 scopus 로고    scopus 로고
    • Refinement of cytogenetic classification in acute myeloid leukemia: Determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
    • Grimwade D, Hills RK, Moorman AV, et al: Refinement of cytogenetic classification in acute myeloid leukemia: Determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 116:354-365, 2010
    • (2010) Blood , vol.116 , pp. 354-365
    • Grimwade, D.1    Hills, R.K.2    Moorman, A.V.3
  • 5
    • 78049502442 scopus 로고    scopus 로고
    • Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A
    • Schlenk RF, Döhner K, Mack S, et al: Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A. J Clin Oncol 28:4642-4648, 2010
    • (2010) J Clin Oncol , vol.28 , pp. 4642-4648
    • Schlenk, R.F.1    Döhner, K.2    Mack, S.3
  • 6
    • 79959959049 scopus 로고    scopus 로고
    • Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: Landmark analysis from a single prospective multicenter trial
    • Stelljes M, Beelen DW, Braess J, et al: Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: Landmark analysis from a single prospective multicenter trial. Haematologica 96:972-979, 2011
    • (2011) Haematologica , vol.96 , pp. 972-979
    • Stelljes, M.1    Beelen, D.W.2    Braess, J.3
  • 7
    • 84867099700 scopus 로고    scopus 로고
    • The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: An integrated-risk adapted approach
    • Cornelissen JJ, Gratwohl A, Schlenk RF, et al: The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: An integrated-risk adapted approach. Nat Rev Clin Oncol 9:579-590, 2012
    • (2012) Nat Rev Clin Oncol , vol.9 , pp. 579-590
    • Cornelissen, J.J.1    Gratwohl, A.2    Schlenk, R.F.3
  • 8
    • 84876089241 scopus 로고    scopus 로고
    • If at first you don't succeed: Stem-cell transplantation for acute myeloid leukemia after first relapse
    • Schiffer CA: If at first you don't succeed: Stem-cell transplantation for acute myeloid leukemia after first relapse. J Clin Oncol 31:1259-1261, 2013
    • (2013) J Clin Oncol , vol.31 , pp. 1259-1261
    • Schiffer, C.A.1
  • 9
    • 84876095248 scopus 로고    scopus 로고
    • Acute myeloid leukemia in first remission: To choose transplantation or not?
    • Stone RM: Acute myeloid leukemia in first remission: To choose transplantation or not? J Clin Oncol 31:1262-1266, 2013
    • (2013) J Clin Oncol , vol.31 , pp. 1262-1266
    • Stone, R.M.1
  • 12
    • 67049164836 scopus 로고    scopus 로고
    • Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: Systematic review and meta-analysis of prospective clinical trials
    • Koreth J, Schlenk R, Kopecky KJ, et al: Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: Systematic review and meta-analysis of prospective clinical trials. JAMA 301:2349-2361, 2009
    • (2009) JAMA , vol.301 , pp. 2349-2361
    • Koreth, J.1    Schlenk, R.2    Kopecky, K.J.3
  • 13
    • 49249095034 scopus 로고    scopus 로고
    • Cytogenetically normal acute myeloid leukemia
    • author reply, 652-653
    • Buchner T, Berdel WE, Kienast J: Cytogenetically normal acute myeloid leukemia. N Engl J Med 359:651, 2008; author reply, 652-653
    • (2008) N Engl J Med , vol.359 , pp. 651
    • Buchner, T.1    Berdel, W.E.2    Kienast, J.3
  • 14
    • 84860342455 scopus 로고    scopus 로고
    • Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia
    • Saber W, Opie S, Rizzo JD, et al: Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia. Blood 119:3908-3916, 2012
    • (2012) Blood , vol.119 , pp. 3908-3916
    • Saber, W.1    Opie, S.2    Rizzo, J.D.3
  • 15
    • 58149388069 scopus 로고    scopus 로고
    • Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: A study by the German Acute Myeloid Leukemia Cooperative Group
    • Büchner T, Berdel WE, Haferlach C, et al: Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: A study by the German Acute Myeloid Leukemia Cooperative Group. J Clin Oncol 27:61-69, 2009
    • (2009) J Clin Oncol , vol.27 , pp. 61-69
    • Büchner, T.1    Berdel, W.E.2    Haferlach, C.3
  • 18
    • 0037217950 scopus 로고    scopus 로고
    • Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: Data from the German AML Cooperative Group (AMLCG) 1992 trial
    • DOI 10.1182/blood-2002-02-0532
    • Kern W, Haferlach T, Schoch C, et al: Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: Data from the German AML Cooperative Group (AMLCG) 1992 Trial. Blood 101:64-70, 2003 (Pubitemid 36025888)
    • (2003) Blood , vol.101 , Issue.1 , pp. 64-70
    • Kern, W.1    Haferlach, T.2    Schoch, C.3    Loffler, H.4    Gassmann, W.5    Heinecke, A.6    Sauerland, M.C.7    Berdel, W.8    Buchner, T.9    Hiddemann, W.10
  • 19
    • 84055218304 scopus 로고    scopus 로고
    • Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management
    • Estey EH: Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol 87:89-99, 2012
    • (2012) Am J Hematol , vol.87 , pp. 89-99
    • Estey, E.H.1
  • 20
    • 84876087623 scopus 로고    scopus 로고
    • Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remission
    • Burnett AK, Goldstone A, Hills RK, et al: Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remission. J Clin Oncol 31:1293-1301, 2013
    • (2013) J Clin Oncol , vol.31 , pp. 1293-1301
    • Burnett, A.K.1    Goldstone, A.2    Hills, R.K.3
  • 21
    • 78649429727 scopus 로고    scopus 로고
    • Reduced mortality after allogeneic hematopoietic-cell transplantation
    • Gooley TA, Chien JW, Pergam SA, et al: Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 363:2091-2101, 2010
    • (2010) N Engl J Med , vol.363 , pp. 2091-2101
    • Gooley, T.A.1    Chien, J.W.2    Pergam, S.A.3
  • 22
    • 84866894134 scopus 로고    scopus 로고
    • Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: A prospective, open-label randomised phase 3 trial
    • Bornhäuser M, Kienast J, Trenschel R, et al: Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: A prospective, open-label randomised phase 3 trial. Lancet Oncol 13:1035-1044, 2012
    • (2012) Lancet Oncol , vol.13 , pp. 1035-1044
    • Bornhäuser, M.1    Kienast, J.2    Trenschel, R.3
  • 23
    • 77449159028 scopus 로고    scopus 로고
    • Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet
    • Döhner H, Estey EH, Amadori S, et al: Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115:453-474, 2010
    • (2010) Blood , vol.115 , pp. 453-474
    • Döhner, H.1    Estey, E.H.2    Amadori, S.3
  • 26
    • 28444473100 scopus 로고    scopus 로고
    • Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: Interaction with other gene mutations
    • DOI 10.1182/blood-2005-05-2164
    • Döhner K, Schlenk RF, Habdank M, et al: Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: Interaction with other gene mutations. Blood 106:3740-3746, 2005 (Pubitemid 41739007)
    • (2005) Blood , vol.106 , Issue.12 , pp. 3740-3746
    • Dohner, K.1    Schlenk, R.F.2    Habdank, M.3    Scholl, C.4    Rucker, F.G.5    Corbacioglu, A.6    Bullinger, L.7    Frohling, S.8    Dohner, H.9
  • 27
    • 0037108111 scopus 로고    scopus 로고
    • Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: A study from the Acute Leukemia French Association (ALFA)
    • Preudhomme C, Sagot C, Boissel N, et al: Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: A study from the Acute Leukemia French Association (ALFA). Blood 100:2717-2723, 2002
    • (2002) Blood , vol.100 , pp. 2717-2723
    • Preudhomme, C.1    Sagot, C.2    Boissel, N.3
  • 28
    • 77449146413 scopus 로고    scopus 로고
    • Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome
    • Dufour A, Schneider F, Metzeler KH, et al: Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome. J Clin Oncol 28:570-577, 2010
    • (2010) J Clin Oncol , vol.28 , pp. 570-577
    • Dufour, A.1    Schneider, F.2    Metzeler, K.H.3
  • 29
    • 84905682636 scopus 로고    scopus 로고
    • Allogeneic stem cell transplantation confers a favorable outcome in patients with NPM1 positive acute myeloid leukemia: Results from a donor vs. No-donor analysis of 309 patients treated in the SAL AML-203 trial
    • abstr 493
    • Rollig C, Bornhauser M, Thiede C, et al: Allogeneic stem cell transplantation confers a favorable outcome in patients with NPM1 positive acute myeloid leukemia: Results from a donor vs. no-donor analysis of 309 patients treated in the SAL AML-203 trial. Blood 118, 2011 (abstr 493)
    • (2011) Blood , vol.118
    • Rollig, C.1    Bornhauser, M.2    Thiede, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.